Dr. Gurdev Dave Singh D.M.D., Ph.D. Net Worth

Dr. Gurdev Dave Singh D.M.D., Ph.D. biography

Dr. Gurdev Dave Singh D.M.D., Ph.D. is the Founder, Chief Medical Officer & Director at Vivos Therapeutics.

What is the salary of Dr D?

As the Founder et Chief Medical Officer & Director of Vivos Therapeutics, the total compensation of Dr D at Vivos Therapeutics is $298,507. There are 1 executives at Vivos Therapeutics getting paid more, with R. Kirk Huntsman having the highest compensation of $455,336.

How old is Dr D?

Dr D is 62, he's been the Founder et Chief Medical Officer & Director of Vivos Therapeutics since . There are 1 older and 3 younger executives at Vivos Therapeutics. The oldest executive at Vivos Therapeutics, Inc. is R. Kirk Huntsman, 63, who is the Co-Founder, Chairman & CEO.

What's Dr D's mailing address?

Gurdev's mailing address filed with the SEC is 9137 S. RIDGELINE BLVD, SUITE 135, , HIGHLANDS RANCH, CO, 80129.

Insiders trading at Vivos Therapeutics

Over the last 4 years, insiders at Vivos Therapeutics have traded over $0 worth of Vivos Therapeutics stock and bought 88,521 units worth $136,211 . The most active insiders traders include Anja B Krammer, Ronald Kirk Huntsman et Bradford K. Amman. On average, Vivos Therapeutics executives and independent directors trade stock every 77 days with the average trade being worth of $22,426. The most recent stock trade was executed by Ronald Kirk Huntsman on 20 June 2023, trading 14,000 units of VVOS stock currently worth $7,420.

What does Vivos Therapeutics do?

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Vivos Therapeutics executives and stock owners

Vivos Therapeutics executives and other stock owners filed with the SEC include:

• R. Kirk Huntsman,
  Co-Founder, Chairman & CEO
• Dr. Gurdev Dave Singh D.M.D., Ph.D.,
  Founder, Chief Medical Officer & Director
• Bradford K. Amman,
  CFO, Treasurer & Sec.
• Ruth Hembree,
  Sr. VP
• Nicholas M. DeGennaro,
  Sr. VP of the Medical Integration Division
• David Bryan Ferre,
  Sr. VP of Marketing
• Cathryn H. Bonar,
  Chief Compliance Officer and Sr. VP of Compliance & Medical Billing
• Edward A. Loew,
  Chief Strategy Officer, Sr. VP of Strategy & Investor Relations Officer
• Susan McCullough,
  Co-Founder & Sr. VP of Operations
• RaeAnn Byrnes,
  Co-Founder and Sr. VP of People, Training & Devel.
• Todd Huntsman,
  Co-Founder & Sr. VP of Manufacturing
• Bradford K. Amman,
  Chief Financial Officer
• Leonard J Sokolow,
  Director
• Anja B Krammer,
  Director
• Ralph Elias Green,
  Director
• Mark F. Lindsay,
  Director
• Gurdev Dave Singh,
  Chief Medical Officer
• Matthew Thompson,
  Director
• Ronald Kirk Huntsman,
  Chief Executive Officer